Immutep (IMMP) Return on Capital Employed (2015 - 2024)
Immutep (IMMP) posted Return on Capital Employed of 64.24% for Q4 2024, up 11.07% on a QoQ basis from 72.24% in Q2 2024, and down 1013.0% year-over-year from 7.04% in Q1 2024.
Immutep (IMMP) Return on Capital Employed (2015 - 2024) Analysis & Trends
Immutep's Return on Capital Employed history runs 8 years deep, the most recent figure standing at 64.24% for Q4 2024.
- Quarterly Return on Capital Employed fell 1013.0% year-over-year to 64.24% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 64.24% (down 1013.0% YoY) and the FY2025 annual result came in at 36.23%, down 803.0% from the prior year.
- Return on Capital Employed was 64.24% for Q4 2024 at Immutep, up from 72.24% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 54.11% in Q4 2023 and bottomed at 76.24% in Q4 2022.
- A 4-year average of 64.37% and a median of 64.24% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 2121 bps — and 2023, when it soared 2214 bps.
- Immutep's Return on Capital Employed stood at 55.03% in 2021, then slumped by 39 bps to 76.24% in 2022, then advanced by 29 bps to 54.11% in 2023, then slipped by 19 bps to 64.24% in 2024.
- Business Quant data shows IMMP's Return on Capital Employed at 64.24% in Q4 2024, 72.24% in Q2 2024, and 54.11% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -31.80% |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -107.40% |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.46% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 21.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 10.19% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -68.84% |
| 10 | Immutep | 569.08 Mn | 569.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -64.24% |
| Jun 30, 2024 | -72.24% |
| Dec 31, 2023 | -54.11% |
| Dec 31, 2022 | -76.24% |
| Dec 31, 2021 | -55.03% |
| Dec 31, 2019 | -117.23% |
| Jun 30, 2019 | -98.26% |
| Dec 31, 2018 | -45.03% |
| Jun 30, 2017 | -36.91% |
| Mar 31, 2017 | -33.84% |
| Jun 30, 2015 | -497.77% |